Imago BioSciences, Inc. Stock-Based Compensation
Imago BioSciences, Inc. reported Stock-Based Compensation of $4.76 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2022-11-09
- Imago BioSciences, Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-09-30 was $1.67M, a 151.13% increase year-over-year.
- Imago BioSciences, Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-06-30 was $1.74M, a 301.38% increase year-over-year.
- Imago BioSciences, Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-03-31 was $1.35M, a 323.51% increase year-over-year.
- Imago BioSciences, Inc. share-based payment arrangement, noncash expense for the quarter ending 2021-12-31 was $809.00K, a 490.51% increase year-over-year.
- Imago BioSciences, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $2.23M, a 422.30% increase from fiscal 2020.
- Imago BioSciences, Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $426.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.41M derived: sum of 2 quarters · filed 2022-11-09 | $4.76M 10-Q · filed 2022-11-09 | $5.57M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | $1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $3.09M 10-Q · filed 2022-08-12 | $3.90M derived: sum of 3 quarters · filed 2022-08-12 | $4.57M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | $1.35M 10-Q · filed 2022-05-12 | $2.16M derived: sum of 2 quarters · filed 2022-05-12 | $2.82M derived: sum of 3 quarters · filed 2022-11-09 | $3.26M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | $809.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $1.47M derived: sum of 2 quarters · filed 2022-11-09 | $1.91M derived: sum of 3 quarters · filed 2022-11-09 | $2.23M 10-K · filed 2022-03-24 |
| 2021-09-30 | $663.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.10M derived: sum of 2 quarters · filed 2022-11-09 | $1.42M 10-Q · filed 2022-11-09 | $1.55M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $434.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $753.00K 10-Q · filed 2022-08-12 | $890.00K derived: sum of 3 quarters · filed 2022-08-12 | $997.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $319.00K 10-Q · filed 2022-05-12 | $456.00K derived: sum of 2 quarters · filed 2022-05-12 | $563.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $244.00K derived: sum of 2 quarters · filed 2022-03-24 | $426.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $289.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $182.00K 10-Q · filed 2021-08-19 |